Proteinase-activated Receptor 2 Promotes Cancer Cell Migration through RNA Methylation-mediated Repression of miR-125b*

Background: Proteinase-activated receptor 2 (PAR2) correlated with cancer metastasis. Results: Down-regulation of miR-125b, which targets Gab2, mediates PAR2-induced cancer cell migration. Conclusion: PAR2 promotes cancer cell migration through RNA methylation-mediated repression of miR-125b. Significance: This study suggests a novel epigenetic mechanism by which miRNA expression is altered to regulate cancer cell migration. Proteinase activated-receptor 2 (PAR2) participates in cancer metastasis promoted by serine proteinases. The current study aimed to test the molecular mechanism by which PAR2 promotes cancer cell migration. In different cancer cells, activation of PAR2 by activating peptide (PAR2-AP) dramatically increased cell migration, whereas knock down of PAR2 inhibited cellular motility. The PAR2 activation also repressed miR-125b expression while miR-125b mimic successfully blocked PAR2-induced cell migration. Moreover, Grb associated-binding protein 2 (Gab2) was identified as a novel target gene of miR-125b and it mediated PAR2-induced cell migration. The correlation of PAR2 with miR-125b and Gab2 was further supported by the findings obtained from human colorectal carcinoma specimens. Remarkably, knock down of NOP2/Sun domain family, member 2 (NSun2), a RNA methyltransferase, blocked the reduction in miR-125b induced by PAR2. Furthermore, PAR2 activation increased the level of N6-methyladenosine (m6A)-containing pre-miR-125b in NSun2-dependent manner. Taken together, our results demonstrated that miR-125b mediates PAR2-induced cancer cell migration by targeting Gab2 and that NSun2-dependent RNA methylation contributes to the down-regulation of miR-125b by PAR2 signaling. These findings suggest a novel epigenetic mechanism by which microenvironment regulates cancer cell migration by altering miRNA expression.

[1]  H. Kung,et al.  Oncomir miR-125b Suppresses p14ARF to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer , 2013, PloS one.

[2]  W. Ruf,et al.  Role of Protease Activated Receptor 1 and 2 Signaling in Hypoxia-Induced Angiogenesis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[3]  M. Hollenberg,et al.  Proteinase-activated Receptor-2 Induces Cyclooxygenase-2 Expression through β-Catenin and Cyclic AMP-response Element-binding Protein* , 2008, Journal of Biological Chemistry.

[4]  A. Daneri-Navarro,et al.  Protease-activated receptor-2 (PAR-2) in cervical cancer proliferation. , 2008, Gynecologic oncology.

[5]  F. Moreau,et al.  Proteinase‐activated receptors induce interleukin‐8 expression by intestinal epithelial cells through ERK/RSK90 activation and histone acetylation , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  V. Kim,et al.  Regulation of microRNA biogenesis , 2014, Nature Reviews Molecular Cell Biology.

[7]  M. Hollenberg,et al.  Proteinase-activated receptor-2 induces cyclooxygenase-2 expression through beta-catenin and cyclic AMP-response element-binding protein. , 2008, The Journal of biological chemistry.

[8]  L. Spagnoli,et al.  Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation. , 2006, The American journal of pathology.

[9]  Xuemei Chen,et al.  Regulation of small RNA stability: methylation and beyond , 2012, Cell Research.

[10]  Hong Zhang,et al.  MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b , 2013, Journal of experimental & clinical cancer research : CR.

[11]  I. Ng,et al.  MicroRNA‐125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B 2 , 2010, Hepatology.

[12]  S. Kitano,et al.  Protease‐activated receptor‐2 regulates cell proliferation and enhances cyclooxygenase‐2 mRNA expression in human pancreatic cancer cells , 2005, Journal of surgical oncology.

[13]  Masaki Mori,et al.  MicroRNA miR-125b is a prognostic marker in human colorectal cancer. , 2011, International journal of oncology.

[14]  Hui-Yun Wang,et al.  Downregulation of Six MicroRNAs Is Associated with Advanced Stage, Lymph Node Metastasis and Poor Prognosis in Small Cell Carcinoma of the Cervix , 2012, PloS one.

[15]  Wenlin Huang,et al.  miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. , 2011, Cancer research.

[16]  H. Versteeg,et al.  Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice. , 2008, Cancer research.

[17]  J. Nichols,et al.  The RNA–Methyltransferase Misu (NSun2) Poises Epidermal Stem Cells to Differentiate , 2011, PLoS genetics.

[18]  Y. Takada,et al.  Hemostasis, Thrombosis, and Vascular Biology: Inhibition of tissue factor signaling suppresses tumor growth , 2014 .

[19]  H. Kitagawa,et al.  Protease-activated receptor-2 expression and the role of trypsin in cell proliferation in human pancreatic cancers. , 2003, International journal of oncology.

[20]  Roger J Daly,et al.  Function, regulation and pathological roles of the Gab/DOS docking proteins , 2009, Cell Communication and Signaling.

[21]  David Smith,et al.  A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. , 2009, Cancer research.

[22]  R. Vessella,et al.  Overexpression of protease‐activated receptors‐1,‐2, and‐4 (PAR‐1, ‐2, and ‐4) in prostate cancer , 2007, The Prostate.

[23]  Yongmei Yin,et al.  MicroRNA-34a Mediates the Autocrine Signaling of PAR2-Activating Proteinase and Its Role in Colonic Cancer Cell Proliferation , 2013, PloS one.

[24]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[25]  Kailai Sun,et al.  MiR‐125b targets BCL3 and suppresses ovarian cancer proliferation , 2011, International journal of cancer.

[26]  W. Ruf,et al.  Tissue factor proangiogenic signaling in cancer progression. , 2012, Thrombosis research.

[27]  M. Hollenberg,et al.  Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma. , 2005, Human pathology.

[28]  M. Gorospe,et al.  The tRNA methyltransferase NSun2 stabilizes p16INK4 mRNA by methylating the 3′-untranslated region of p16 , 2012, Nature Communications.

[29]  Y Sheng,et al.  Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration , 2009, Oncogene.

[30]  Biao Wu,et al.  TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620 , 2013, Tumor Biology.

[31]  Shuji Mori,et al.  Physiology and pathophysiology of proteinase-activated receptors (PARs): PAR-2-mediated proliferation of colon cancer cell. , 2005, Journal of pharmacological sciences.

[32]  K. Mimori,et al.  Clinical Significance of GAB2, a Scaffolding/Docking Protein Acting Downstream of EGFR in Human Colorectal Cancer , 2014, Annals of Surgical Oncology.

[33]  F. Watt,et al.  The RNA Methyltransferase Misu (NSun2) Mediates Myc-Induced Proliferation and Is Upregulated in Tumors , 2006, Current Biology.

[34]  C. Croce,et al.  MicroRNAs in Cancer. , 2009, Annual review of medicine.

[35]  C. Benz,et al.  Coordinate Suppression of ERBB2 and ERBB3 by Enforced Expression of Micro-RNA miR-125a or miR-125b* , 2007, Journal of Biological Chemistry.

[36]  H. Körner,et al.  Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasis , 2006, The Journal of pathology.

[37]  I. Ng,et al.  MicroRNA-125 b Suppressesed Human Liver Cancer Cell Proliferation and Metastasis by Directly Targeting Oncogene LIN , 2010 .

[38]  M. Gorospe,et al.  Methylation by NSun2 Represses the Levels and Function of MicroRNA 125b , 2014, Molecular and Cellular Biology.

[39]  M. Laburthe,et al.  Protease-activated Receptor 2 in Colon Cancer , 2004, Journal of Biological Chemistry.

[40]  K. Tsai,et al.  Epigenetic control of the expression of a primate-specific microRNA cluster in human cancer cells , 2009, Epigenetics.

[41]  A. Luo,et al.  MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1 , 2013, Oncogene.

[42]  A. Schneeweiss,et al.  Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk , 2011, Breast Cancer Research and Treatment.

[43]  M. Hollenberg,et al.  Proteinase-activated receptors (PARs) – focus on receptor-receptor-interactions and their physiological and pathophysiological impact , 2013, Cell Communication and Signaling.

[44]  K. Venkatasubbarao,et al.  A miRNA Signature of Chemoresistant Mesenchymal Phenotype Identifies Novel Molecular Targets Associated with Advanced Pancreatic Cancer , 2014, PloS one.

[45]  Weiying Zhou,et al.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. , 2014, Cancer cell.

[46]  S. Hawthorne,et al.  Amplification of MMP‐2 and MMP‐9 production by prostate cancer cell lines via activation of protease‐activated receptors , 2004, The Prostate.

[47]  B. Neel,et al.  The "Gab" in signal transduction. , 2003, Trends in cell biology.

[48]  M. Santoro,et al.  Mast cells have a protumorigenic role in human thyroid cancer , 2010, Oncogene.

[49]  A. Scorilas,et al.  Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.